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ABSTRACT 
The delivery of a drug to the preferred site of action is referred to as drug targeting. The benefits of drug targeting are a reproducible and 
controlled release rate of the therapeutic compound, which forestalls overdose. Due to the potential to treat colonic diseases with minimum side 
effects, colon targeting has become of high interest over the last decades. Inulin was investigated for its potential as encapsulation material 
regarding its enzymatic degradability and its drug release behaviour. Inulin is a polysaccharide with a widespread range of therapeutic uses such 
as a carrier in a drug delivery vehicle, as a diagnostic/analytical tool or as a dietary fibre with additional health benefits. In the main, much 
research has focused on inulin as a drug delivery carrier for colon-specific drug delivery. The justification for this is its potential to survive in the 
stomach’s acidic environment. This unique stability and strength are utilized in many ways to deliver drugs safely to the colon, where they can be 
easily absorbed through the gut epithelium into the blood. There are also some proofs that inulin’s prebiotic features also lead to health benefits, 
mainly for patients with inflammatory bowel disease or in the prevention of colonic cancer. Inulin based hydrodynamic research will be useful to 
discover the potential of inulin. 
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1. Introduction 
The delivery of a drug to the desired site of action is referred 
to as drug targeting. The benefits of drug targeting are a 
reproducible and controlled release rate of the therapeutic 
compound, which forestalls overdose. Moreover, the 
unwanted effects and toxicity of drug are minimized 1. Now 
day’s colon targeting has become of high interest, due to the 
potential to treat colon specific diseases with minimized side 
effects 2. For colon specific targeting, it is essential that the 
therapeutic formulation bypass the stomach and the small 
intestine in a non-degraded form 3. Various bio-polymers like 
polysaccharides have been investigated as prospective 
encapsulation materials for therapeutic substances 4. Inulin 
is a versatile plant-derivative carbohydrate with the benefits 
of soluble dietary fiber 5. Inulin is not digested or absorbed in 
the stomach and in the small intestine but is fermented in the 
colon by advantageous bacteria. Inulin functioning as a 
prebiotic has been linked with enhancing the gastrointestinal 
system and the immune system. The natural polymer inulin 
has numerous applications in the food and pharmaceutical 
industry due to its exclusive chemical and physical 
properties 6,7. Inulin is non-toxic biopolymer and its β(2-1)-
glycosidic-linked fructosyl units are indigestible by the upper 
gastrointestinal tract of humans 8. However, inulin can be 
partly or totally metabolized by the colonic microbiota to 
acetate, propionate, lactic acid, hydrogen, and carbon dioxide 
9-11. Consequently, inulin is used as a prebiotic food element 
with accredited positive effects on human health. 
Stevens et al. reported that ingested inulin is not altered in 
monosaccharides by the digestives juices. Therefore, the 
glycemia and the level of insulin in the blood remain steady 
and the inulin reaches in the large intestine where it is 
fermented 12. This condition is caused by a specific bond, 
β(2-1) linked fructose present in the molecule of inulin 13, 
which confers that it cannot be processed by the human 
digestive system so the inulin passes through stomach, small 
intestine without degradation and stops in the large intestine 
where it produces a healthy microflora (Bifidobacterium). 
This shows that inulin is a natural prebiotic (an ingredient 
that belongs to the prebiotic family requires two 
stipulations: it should not be digested by the digestive 
enzyme, and it can only undergo fermentation in the colon. 
Various physiological effects implemented by inulin are 
summarized in Table 1. 
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Table 1: The physiological function of inulin in the large 
bowel 14 
Large Bowel Inulin Functionality  
Attenuation of faecal pH              + 
 
Production of short chain fatty acids              + 
 
Promote growth of Bifidobacteria              + 
 
Increase stool frequency              + 
 
Decrease intestinal transit time              - 
 
Increase stool weight              - 
 
Improvement of stool consistency              + 
 
 
Now a day’s inulin is a promising molecule with researches 
and applications in medicine, pharmacology or food 
industry, because of its bioactivity 15. In medicine, inulin has 
manifold functions, such as: maintaining the microflora of 
the colon, improving metabolism, maintaining 
gastrointestinal health 16. A relative latest finding confirmed 
that pure inulin promoted Collinsella growth in the 
gastrointestinal tract. in addition, Smecuol et al. 17 found that 
inulin-type fructans contribute to the rise of Bifidobacterium 
infantis probiotic strains that have a positive effect on 
subjects with active coeliac disease, a chronic inflammation 
of the intestinal mucosa ensuing from an extreme immune 
response to dietary gluten in genetically predisposed 
individuals. The colonic disorder is quite hard to treat 
because orally administrated therapeutics are absorbed in 
the stomach and intestine levels and they do not reach the 
colon, while intravenous administrated therapeutics are 
eliminated from the body before reaching the colon. The fact 
inulin is not degraded or absorbed in the stomach or in the 
small intestine, but it is degraded by colonic bacteria, various 
inulin based pharmaceutical formulations have been 
developed that can be used as a promising carrier for 
targeting of drugs into the colon 13, 18.  
2. Inulin  
2.1 Origin and Identity 
Rose discovered Inulin, a German scientist, in 1804 from the 
roots of Inulaheleniumfound "a peculiar substance" from 
plant origin, a genus of perennial herbs of the group 
Composit~e, inhabitants of the temperate regions of Europe, 
Asia, and Africa 19. The substance was named inulin but was 
also known by other names such ashelenin, alantin, 
meniantin, dahlin, sinantemin and sinisterin. In the mid of 
the 19th century, the biochemicalproduction was elucidated. 
Inulin comes under a general class of fructose-containing 
polymers known as fructans. Fructans assist as storage 
polymers in numerous members of the Composit~e family 
such as Cichoriumintybus (chicory), Inulahelenium 
(elecampane), Taraxacumofficinalis (dandelion) and 
Helianthus tuberosus (Jerusalem artichoke). Inulin pulls out 
from chicory is a natural polydisperse carbohydrate 20. It is a 
fructan which mainly comprises linear chains of 1, 2-[3-
1inked d-fructofuranose units bound by an (od-132) type 
linkage (as in sucrose) to a terminal glucose moiety. The 
fructans that are found in the dicotyledons, and in some 
monocotyledons, are of this type. By assessment, fructans 
primarily composed of linear fructose units bound by a [3-
(2---~6) glycosidic bond. The gross molecular formula of 
inulin is GF with G being a terminal glucosyl unit, F shows 
the fructosyl units and n demonstrating the number of 
fructosyl units [Fig. 1] 21. 
 
Figure 1: Basic structure of Inulin 
2.2 Source and preparation 
Inulin occurs in thousands of plant species, including 
asparagus, banana, garlic, and onion. The chicory (Cichorium 
intybus) root is the main commercial source where inulin 
constitutes 16% to 18% of the dry matter. Some inulin is also 
obtained from tubers of Jerusalem artichoke (Helianthus 
tuberosus L.). Inulin has been taken by humans since ancient 
times. Before the potato was introduced into Western 
Europe in the latter half of the 16th century, the Jerusalem 
artichoke tuber (14%-19% inulin) was a main source of 
carbohydrate. Chicory roots (and Jerusalem artichoke 
tubers) must be processed soon after harvesting (possibly on 
the same day, but not more than 7 days after harvesting) 
because they deteriorate quickly. The harvested roots are 
washed, sliced, and extracted with hot water. Colloidal 
materials, colored substances, and other solubles (salts, 
amino acids, sugars, etc.) are isolated from the extract by a 
purification/clarification process involving treatment with 
calcium hydroxide (lime) to precipitate protein, followed by 
treatment with CO2 to counteract the alkaline mixture and to 
precipitate any calcium ions in solution as calcium 
carbonate, centrifugation, filtration through an adsorbent 
and/or activated carbon, and ion exchange, a process 
analogous to that used in purifying sucrose extracts. The 
extract is then concentrated by evaporation and spray-dried 
followed by ultrafiltration. The inulin may also be recovered 
by crystallization or precipitation. Even with extensive care, 
inulin extracted from chicory roots is still mainly a mixture 
of oligosaccharides. The commercial preparation contains 
2% monosaccharides, 5% disaccharides, and 93% molecules 
of DP 3-60, with an average DP of 8-10. The maximum 
average DP of chicory root inulin is about 15, representing a 
comparatively high percentage of molecules of low DP. The 
maximum amount of inulin in chicory roots is about 18% 
(dry basis). 22 
3. Controlled and targeted drug release by Inulin 
complexes 
Inulin offers controlled release of therapeutics to the colon 
because it provides protection against the acidic 
environment in the stomach for the encapsulated drug as 
well as allowing degradation in the colon in the presence of 
the colonic microbiota 23. The potential of inulin, as a coating 
system, with its effectiveness in controlled drug released was 
tested by 24 swelling tests, water vapour transmission tests 
and drug permeability in colonic media was evaluated using 
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polymethacrylates (eudragit) with and without inulin. In the 
absence of inulin polymers, drug release was controlled by 
the pH of the media. The swelling behaviour and permeation 
of drug were observed more with inulin dependent system 
as compared to the pH-dependent polymers (24). Drugs with 
low water solubility have low bioavailability due to partial 
solubility and thus present a dilemma in successful drug 
delivery 25. Irbesartan tablet was prepared by mixing it with 
inulin and poly (acrylic acid) grafted inulin. The flower-like 
platelets of inulin, surrounding the drug were observed that 
consequently increased the drug dissolution. Increasing 
inulin concentration increased the drug solubility 26. Quality 
of inulin to form aggregates in different solutions like water, 
DMSO and CnTAB (cetyl trimethylammonium bromides) and 
CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate) can be useful for the solubilisation and 
encapsulation of drugs 27. The physicochemical interaction 
with cationic amphiphilic surfactants CnTAB of varied alkyl 
chain length was studied at a variable concentration of 
CnTAB and inulin. Increasing concentration of alkyl group 
was reported to strengthen the inulin aggregates up to a 
moderate concentration of the amphiphile. At very high 
concentrations the amphiphile formed free micelles 28. Inulin 
incorporation in a three-layer coating system has also been 
reported by Ravi et al. A tablet made up of the drug Diltiazem 
HCl matrixed with chitosan and guar gum was used. This 
tablet was bounded by inulin (inner) and shellac (outer) 
layer. The outer and inner coats were intended to provide 
protection against gastric and intestinal environments, 
respectively. The drug was then released in the colon with 
the degradation of the other two polysaccharides 29, 30. 
Due to its resistance to the gastric fluid and degradation in 
the distal intestine inulin was used as a promising carrier to 
deliver butyrate to its site of action. The study was 
conducted in order to recognize the apoptotic potential 
against colonic cancerous cells and showed that the use of 
inulin provided secure targeting of butyrate to its site of 
action 31. 
3.1 Hydrogels of Inulin 
A range of inulin hydrogels has been developed to be used as 
potential carriers for the targeting of drugs with variable 
composition into the colon 32. Appropriate degradation rate, 
bioadhesive nature, mechanical and hydrolytic resistance are 
the desirable characters imposed by polysaccharide-poly 
amino acid gels that can be helpful for the successful delivery 
of drug to its targeted site 33. For example, cross-linking of 
Inulin with Methacrylic Anhydride and Succinic Anhydride 
(INU-MA-SA) resulted in the production of a derivative that 
is reluctant to degradation in the stomach and is compatible 
to intestinal degradation 34. This inulin derivative (INU-MA-
SA) has also been tested using Differential Scanning 
Calorimetry (DSC) for delivery of Non-Steroidal Anti 
Inflammatory Drugs (NSAIDs). These drugs have the 
potential to irritate gastric mucosae 35. Diflunisal was the 
NSAID (the drug used to treat early morning angina) used 
exclusively for this study at pH 4.0 and 7.4. Use of inulin 
provided defence from the acidic environment in the 
stomach to the drug and was found to be more useful to 
avoid any side effects caused as a result of NSAIDs in the 
stomach. Degradation of inulin occurred in the colon in the 
presence of the enzyme inulinase 23. 
Another study has reported INU-MA-SA hydrogels to be used 
in conjunction with a ß-poly[N-(2-hydroxyethyl)-D, 
Laspartamide]. This polysaccharide/poly (amino acid) UV 
induced hydrogel system was used to deliver protein and 
peptide-based drugs to the colon. Immunoglobulin G (IgG) 
was selected as a model drug. These hydrogels were 
inulinase degradable, compatible with epithelial cells and the 
released protein reserved their biological activity. 33 Inulin a-
ß-polyaspartylhydrazide gels (INUPAH) were made from a-
ßpolyaspartylhydrazide (PAHy), a synthetic and 
biocompatible amino acid. The gel was loaded with two 
therapeutic peptides, glutathione and oxytocin, respectively. 
The gel was apposite for intestinal delivery of these peptides 
for the management of inflammatory bowel disease 36. 
Another hydrogel of inulin was obtained by cross-linking 
inulin derivatives (inulin with divinyl sulfone and succinic 
anhydride) with trimethylolpropane tris (3-
mercaptopropionate). The anti-cancerous drug, 2-
Methoxyestradiol was complexed with this hydrogel and 
found to be apoptopic against Caco-2-cell lines. Also, this gel 
was reported to be appropriate for colon drug delivery 
because of its degradation by inulinase and esterase 37. 
3.2 Solid dispersion 
The solid dispersion technology is another method utilised 
for introducing therapeutics. Here, the therapeutics is 
dispersed in a hydrophilic matrix 38. In this study by Visser, 
an inulin matrix (Mw: 4kDa) was observed to improve 
solubility and drug release rates for weakly water-soluble 
drug TMC240 along with an increase in drug loading 
threshold (38). Inulin and its derivatives are suitable 
candidates for solid dispersion drug delivery for a heavy load 
of lipophilic drugs. Inulin (Mw: 2.3kDa), Inulin derivative 
Inutec SP1 (inulin back bone with covalently linked 
lipophilic alkyl side chains), and polyvinylpyrrolidone were 
spray dried to form a solid dispersion in which the drug was 
loaded. The drug encapsulation was reported using DSC. All 
three formulations gave excellent physical stability with 
Inutec SP1 with utmost dissolution rate owing to its surface-
active nature 39.  
Inulin has also been used as a solid dispersion to give 
stability to highly unstable, easily degradable and lipophilic 
Δ9- tetrahydrocannabinol (THC). A blend of THC and inulin 
in a solution of water and tertiary butyl alcohol was 
lyophilised to make a solid dispersion and stored for 7 days 
at 20oC at 45% relative humidity. This exposure led to total 
degradation of unprotected THC in 40 days while solid 
dispersed THC showed only 20% degradation even after 300 
days. The high aqueous dissolution rate of the tablets 
prepared from THC incorporated in inulin matrix was 
recommended to improve bioavailability in sublingual 
administration 40.  
In another study based on the stabilizing capability of inulin, 
it was found that inulin is a better stabiliser than trehalose. 
The research was targeted to formulate an orally ingestible 
tablet that can be used to eradicate endotoxins released 
during sepsis. The compaction behaviour of inulin and 
trehalose and their effect on the loaded bovine isolated 
alkaline phosphate (BIAP) was observed. Trehalose tends to 
crystallize upon compaction and had moisture in it while 
inulin had low friability, was stable at high relative 
humidities and offered good tabletting strength. Thus, inulin 
had a benefit over trehalose as a stabiliser of BIAP in the 
form of a tablet 41. 
4. Conclusion 
Inulin is versatile polysaccharide that can be used as a drug 
delivery vehicle, as a diagnostic tool or as a dietary fibre with 
widespread health benefits. In this review study, the drug 
targeting potential of inulin has been reviewed. Inulin’s 
chemical structure makes that it is not degraded by the 
upper gastrointestinal tract. Gut micro-biota, however, are 
able to metabolize inulin. This unique stability and strength 
are utilized in a number of ways to deliver drugs safely to the 
colon where they can be easily absorbed through the gut 
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epithelium into the blood. There are some proofs that 
inulin’s prebiotic features also lead to health benefits, mainly 
for patients with inflammatory bowel disease or in the 
prevention of colonic cancer. Inulin based hydrodynamic 
research will be valuable to find out inulin potential. In 
addition, more and more research is being made with 
chemically tailored inulins, making it likely that more 
applications will be established for this versatile 
polysaccharide. 
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